All Day Stocks

[budfoxfun]

$PSID One of the biggest barriers to delivering rapid diagnosis and care during a biological outbreak is about to be eliminated, said Lyle L. Probst, President, CEO and Founder of PositiveID Corporation’s (PSID) ExcitePCR subsidiary.

When asked what makes ExcitePCR’s FireflyDX™ technologies different than other pathogen detection solutions, Probst said, “Sample preparation takes place inside our FireflyDX systems, which means our customers can go from sample capture to answer in 30 minutes or less. On top of that, the FireflyDX devices are small, portable PCR-based units which can be used virtually anywhere around the world. These are just some of the things that set our pathogen detection systems apart from other solutions.” “We’ve already shown in-lab comparability to the ABI 7500 with our FireflyDX for pathogens ranging from MRSA to swine flu, as well as when detecting other bio-threats like anthrax or when looking for the presence of genetically modified foods (GMOs),” Probst said. “The difference we believe the FireflyDX products will deliver is the ability to incorporate sample prep within the entire PCR process. This allows caregivers, first responders, animal health workers and others to have extremely accurate results within 30 minutes or less from the moment of sample capture to PCR-derived results.” {NOTE: Thermo Fisher Scientific’s ABI 7500 is viewed by most industry professionals as the “gold standard” for benchtop-based PCR testing. https://finance.yahoo.com/news/internal-sample-preparation-small-size-120000072.html

#news